Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products
Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products
浙江东方基因生物的部门获得美国食品药品管理局批准注册两款产品
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册